Ark ETF Trust · net assets $1.56B · 33 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.8% · STIV: 0.2%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $73.4M | $320M | $216M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $180M | $184M | $248M |
| Net realized gain (non-derivative) | $-4.43M | $3.24M | $27.3M |
| Net unrealized appreciation (non-derivative) | $183M | $284M | $-167M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| 10x Genomics Inc EC | $146M | 9.39% |
| Twist Bioscience Corp EC | $120M | 7.73% |
| Tempus Ai Inc EC | $102M | 6.56% |
| Crispr Therapeutics Ag EC | $97.9M | 6.29% |
| Personalis Inc EC | $85.3M | 5.47% |
| Absci Corp EC | $80M | 5.14% |
| Guardant Health Inc EC | $73.8M | 4.74% |
| Illumina Inc EC | $73.8M | 4.74% |
| Eli Lilly & Company EC | $73M | 4.68% |
| Caredx Inc EC | $66.9M | 4.30% |
| Natera Inc EC | $64.3M | 4.13% |
| Beam Therapeutics Inc EC | $58.8M | 3.78% |
| Compass Pathways PLC EC | $50.7M | 3.25% |
| Recursion Pharmaceuticals Inc EC | $40.9M | 2.63% |
| Adaptive Biotechnologies Corp EC | $40.1M | 2.57% |
| Veracyte Inc EC | $39.7M | 2.55% |
| Nurix Therapeutics Inc EC | $39M | 2.51% |
| Butterfly Network Inc EC | $33.9M | 2.18% |
| Schrodinger Inc EC | $30.9M | 1.99% |
| Genedx Holdings Corp EC | $29.1M | 1.87% |
| Intellia Therapeutics Inc EC | $28.5M | 1.83% |
| Ionis Pharmaceuticals Inc EC | $27.5M | 1.77% |
| Alamar Biosciences Inc EC | $24.3M | 1.56% |
| Prime Medicine Inc EC | $21.9M | 1.41% |
| Generate Biomedicines Inc EC | $17.3M | 1.11% |
| Arcturus Therapeutics Holdings Inc EC | $15.8M | 1.01% |
| Cerus Corp EC | $15.5M | 1.00% |
| 908 Devices Inc EC | $15.3M | 0.98% |
| Pacific Biosciences Of California Inc EC | $14.9M | 0.96% |
| Ataibeckley Inc EC | $11.8M | 0.76% |
| Scribe Therapeutics Inc EC | $6.86M | 0.44% |
| Quantum-si Inc EC | $4.82M | 0.31% |
| Goldman Sachs Financial Square Treasury Obligations Fund STIV | $2.81M | 0.18% |
Loading...
